Skip to main content

Table 3 Prescription of antipsychotic drugs at admission and discharge, p-values of differences and chlorpromazine equivalent doses at discharge (n = 486).

From: Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study

FGA

    

Antipsychotic drug

Admission N(%)

Discharge

N(%)

Adjusted P-value for the difference*

Chlorpromazine equivalent dose at discharge

mean (SD) range

Low-potency

    

Levomepromazine (Nozinan®)

31(6.4)

39(8.2)

0.248

87 (99) 10–400

Chlorpromazine (Largactil®)

29(6.0)

28(5.8)

0.793

171 (104) 4–400

Klorprotixene (Truxal ®)

13(2.7)

18(3.7)

0.501

250 (145) 111–667

Thioridazine (Melleril®)

1(0.2)

1(0.2)

 

75

Medium potency

    

Perphenazine (Trilafon®)

24(4.9)

17(3.5)

0.248

187 (121) 50–400

Perphenazine decanoate (Trilafon depot®)

37(7.6)

49(10.1)

0.049

488 (243) 203–1624

Perphenazine total number patients

60(12.4)

65(13.4)

0.537

 

Zuclopentixol (Cisordinol®)

15(3.1)

21(4.3)

0.501

58 (27) 28–128

Zuclopenthixol decanoate (Cisordinol Depot®)

39(8.0)

49(10.1)

0.247

115 (61) 34–357

Zuclopenthixol total number patients

51(10.5)

68(14.0)

0.049

 

Dixyrazine (Esucos®)

4(0.8)

6(1.2)

0.536

300 (300-300)

Prochlorperazine (Stemetil®)

1(0.2)

1(0.2)

 

1000

High-potency

    

Haloperidol (Haldol®)

8(1.7)

10(2.0)

0.613

144 (85) 33–267

Haloperidol decanoate (Haldol depot®)

6(1.2)

7(1.4)

0.524

400 (164) 179–714

Haloperidol total number patients

14(2.9)

15(3.1)

0.793

 

Flupenthixol (Fluanxol®)

2(0.4)

3(0.6)

0.537

266 (85) 33–267

Flupenthixol decanoate (Fluanxol depot®)

5(1.0)

6(1.2)

0.793

247 (129) 153–429

Flupentixol total number patients

7(1.4)

9(1.9)

0.613

 

SGA

    

Olanzapine (Zyprexa®)

122 (25.1)

141 (29.0)

0.049

350 (137) 100–800

Risperidone (Risperdal®)

39(8.0)

43(8.9)

0.613

234 (107) 67–467

Risperidone long-acting injection (Risperdal Consta®)

57(11.7)

62(12.8)

0.565

311 (94) 179–536

Risperidon total number patients

91 (18.7)

93 (19.1)

0.793

 

Quetiapine (Seroquel®)

42(8.6)

46(9.5)

0.613

690 (533) 33–2800

Clozapine (Leponex®, Clozapine®)

37(7.6)

39(8.0)

0.524

 

Aripiprazole (Abilify®)

29(6.0)

30(6.2)

0.793

285 (94) 133–400

Ziprazidone (Zeldox®)

23(4.7)

24(4.9)

0.793

173 (90) 33–266

Amisulpride (Solian®)

11(2.3)

14(2.9)

0.537

600 (353) 100–1200

Sertindole (Serdolect®)

0(0)

1(0.2)

 

missing

Total dose

   

450 (347) 25–2800

  1. * Logistic regression for repeated observations (GEE). Exchangeable working correlations were used except (for stability reasons) for haloperidol depot and clozapine. For prochlorperazine and sertindol no tests were performed (at most one occasion of use at admission resp. discharge). The results were adjusted for multiple comparisions with Benjamini-Hochberg's method.